Crescita Therapeutics Inc. (CRRTF.PK,CTX.TO), Monday announced its first-quarter financial results, reporting a net loss of C$1.160 million, or C$0.06 a share, compared to C$0.932 million, or C$0.05 a share, last year.
Operating loss amounted to C$1.2 million compared to C$1.1 million in the earlier year.
Revenues increased to C$5.6 million from C$3.5 million in the prior year.
Crescita's stock closed trading at $0.5731 on the OTC Markets on Friday.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.